|Bid||0.11 x 0|
|Ask||0.12 x 0|
|Day's Range||0.10 - 0.13|
|52 Week Range||0.06 - 0.35|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Preliminary research data indicate that cannabinoid and stilbenoid formulations prepared using the Cryolisation process increase absorption rates of cannabinoid compounds 4 – 5 times over consumption of cannabinoid compounds alone.
Subject to the negotiation of a definitive agreement, NeutriSci and Nutritional High will develop products which will be manufactured and distributed by Nutritional High in US states which permit the sale of cannabis infused products. The tablets will combine the benefits of NeutriSci and Nutritional High’s existing technologies and ingredient mixes. The tablets will be quick dissolving and will offer a measured dose of pure THC or CBD oil, combined with the powerful bio-availability & antioxidant properties of pterostilbene.
The Rogers Cup, which will be held in Montreal from August 3 – 12, 2018, was identified as an ideal fit for neuenergy® and our primary consumer base of professionals with an active, healthy lifestyle. In keeping with NeutriSci’s mission to bring awareness of neuenergy® to as many people as possible, neuenergy® will be featured as a Bronze Sponsor of the tournament, with a dedicated booth in the spectator’s gallery. Genie Bouchard and several other neuenergy® Olympic ambassadors will be on-hand to sign autographs and promote neuenergy®. Rogers Cup participants will be able to sample and experience neuenergy® in the retail area on site.
Vancouver, British Columbia--(Newsfile Corp. - March 1, 2018) - NeutriSci International Inc. (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9) (the "Company" or "NeutriSci") the innovator and pioneer behind neuenergy®, is pleased to announce the filing of a new U.S. provisional patent application (United States Provisional Patent No. 62/628,735; Compositions Comprising Co-crystals of Stilbenoids and Cannabinoids) relating to compositions comprising pterostilbene and other stilbenoids in formulations which improve the dissolution rate and bioavailability of cannabinoid compounds.Cannabinoids ...
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2018) - NeutriSci International Inc. (TSXV: NU) (OTCQB: NRXCF) (FSE: 1N9) (the "Company" or "NeutriSci") and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) ("Lexaria") are pleased to announce that they have revised their joint venture agreement such that NeutriSci now owns 100% of Ambarii Trade Corporation ("Ambarii"), and Lexaria has granted to NeutriSci, an Intellectual Property License and Supply Agreement (the "License Agreement") for the manufacturing and sale of CBD ...
KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / February 26, 2018 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria") a drug delivery platform innovator, announces ...
NeutriSci International Inc. , the innovator and pioneer behind neuenergy®, is pleased to announce a one-year sponsorship deal with Canadian and International tennis...
NeutriSci International Inc. , the innovator and pioneer behind neuenergy®, is pleased to announce that its partner in Japan and South Korea for Ambarii Corporation...